🇺🇸 FDA

Company profile · Sponsor

PMV

PMV Pharmaceuticals

PMVP · NYSE pharma PRINCETON, NJ, USA
Pipeline
6
Drugs
0
Patents
8

Quick answer

PMV (PMVP) is a pharma company. headquartered in PRINCETON, NJ, USA. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker PMVP
Exchange NYSE
Company type pharma
Headquarters PRINCETON, NJ, USA
SEC CIK 0001699382

Pipeline (6)

Search pipeline →

  1. PC14586

    PMV

    Locally Advanced or Metastatic Solid Tumors Harboring a TP53 Y220C Mutation

    phase 2 small molecule active

    1 trial

  2. rezatapopt

    PMV

    Advanced Solid Tumor

    phase 2 small molecule active

    1 trial

  3. Azacitidine

    PMV

    Myelodysplastic Syndrome

    phase 1 small molecule active

    1 trial

  4. PC14586

    PMV

    Healthy Volunteers

    phase 1 small molecule completed

    3 trials

  5. [14C]-PC14586

    PMV

    Healthy Male Volunteers

    phase 1 small molecule completed

    1 trial

  6. metformin hydrochloride 500 mg tablet

    PMV

    TP53 Y220C Mutation

    phase 1 small molecule active

    1 trial

Patents (8)

Search patents →

  1. US 12428406

    Methods and compounds for restoring mutant p53 function

    Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12419880

    Companion diagnostic tool for mutant p53 reactivating compounds

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11963953

    Deuterated compounds for restoring mutant p53 function

    Expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11938124

    Combination therapy for treatment of cancer

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11926632

    Methods and compounds for restoring mutant p53 function

    Expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11814373

    Methods and compounds for restoring mutant p53 function

    Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11807644

    Methods and compounds for restoring mutant p53 function

    Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11731953

    Methods and compounds for restoring mutant p53 function

    Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is PMV?

PMV (PMVP) is a pharma company. headquartered in PRINCETON, NJ, USA. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does PMV sponsor?

We track 6 ClinicalTrials.gov-linked programs for PMV, including PC14586 and 5 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does PMV company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.